SubscribeIn the News

TEST ARTICLE

Friday, April 27th, 2012 | Venture Investors

AERPIO ANNOUNCES POSITIVE PHASE 1 DATA ON FIRST-IN-CLASS TIE2 ACTIVATOR, AKB-9778, IN DEVELOPMENT FOR DIABETIC MACULAR EDEMA

Friday, April 20th, 2012 | Healthcare

AKEBIA MEETS PRIMARY ENDPOINT IN PHASE 2 STUDY OF ONCE-DAILY, ORAL ANEMIA TREATMENT, AKB-6548

Thursday, April 5th, 2012 | Healthcare

VIRENT BIOJET FROM VIRDIA CELLULOSIC SUGARS PASSES RIGOROUS TESTS

Monday, March 26th, 2012 | Clean Tech

EUTHYMICS BIOSCIENCE, INC. INITIATES CLINICAL TRIAL FOR NEW DRUG TARGETED FOR ADULT ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)

Thursday, March 22nd, 2012 | Healthcare

VENTURE MI II INVESTS $15M IN WISCONSIN EARLY-STAGE FUND

Monday, March 19th, 2012 | Venture Investors

INVIRAGEN HAND, FOOT AND MOUTH DISEASE VACCINE GENERATES IMMUNE RESPONSE IN 100% OF STUDY PARTICIPANTS

Monday, March 12th, 2012 | Healthcare
« Previous Entries

Categories

Archive

Search